
Ayala Pharmaceuticals AYLA
Geschäftsbericht 2022
hinzugefügt 31.03.2023
Ayala Pharmaceuticals EV/EBITDA 2011-2026 | AYLA
EV/EBITDA Jährlich Ayala Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.785 | -4.14 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.785 | -4.14 | -1.68 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
-44.8 | $ 2.08 | -14.4 % | $ 214 M | ||
|
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | ||
|
Altimmune
ALT
|
-1.66 | $ 4.2 | -2.67 % | $ 298 M | ||
|
Apellis Pharmaceuticals
APLS
|
-6.39 | $ 20.24 | -3.44 % | $ 2.55 B | ||
|
Aptorum Group Limited
APM
|
29.4 | $ 0.8 | 1.87 % | $ 4.36 M | ||
|
Aprea Therapeutics
APRE
|
-248 | $ 0.88 | -3.72 % | $ 3.18 M | ||
|
Aptevo Therapeutics
APVO
|
-2.13 | $ 7.2 | -1.64 % | $ 1.99 M | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Aquestive Therapeutics
AQST
|
-7.26 | $ 4.1 | 2.37 % | $ 356 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-2.37 | $ 8.35 | 1.46 % | $ 225 M | ||
|
Ardelyx
ARDX
|
0.0336 | $ 6.37 | -2.75 % | $ 1.54 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
argenx SE
ARGX
|
-39.4 | $ 756.71 | -1.33 % | $ 25 B | ||
|
Armata Pharmaceuticals
ARMP
|
-5.76 | $ 10.91 | 1.58 % | $ 394 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-4.86 | $ 25.33 | -6.1 % | $ 3.22 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
Artelo Biosciences
ARTL
|
1.49 | $ 1.15 | -3.36 % | $ 2.32 M | ||
|
Arvinas
ARVN
|
-20.4 | $ 12.97 | -2.3 % | $ 920 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
-30.8 | $ 61.74 | -2.42 % | $ 8.26 B | ||
|
Ascendis Pharma A/S
ASND
|
-15.7 | $ 231.56 | -0.83 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.39 | -1.63 % | $ 8.16 B | ||
|
Actinium Pharmaceuticals
ATNM
|
-1.3 | $ 1.17 | -0.85 % | $ 35.2 M | ||
|
Atossa Therapeutics
ATOS
|
6.49 | $ 4.39 | -0.9 % | $ 553 M | ||
|
Atara Biotherapeutics
ATRA
|
-4.49 | $ 5.01 | -7.47 % | $ 37.5 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
-7.69 | $ 14.14 | -0.21 % | $ 1.9 B | ||
|
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | ||
|
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.68 | -1.75 % | $ 429 M | ||
|
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | ||
|
Atea Pharmaceuticals
AVIR
|
-0.282 | $ 4.69 | 0.21 % | $ 395 M | ||
|
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
-12 | $ 4.54 | 2.44 % | $ 387 M | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
Axon Enterprise
AXON
|
-63.9 | $ 570.5 | 5.18 % | $ 43.2 B | ||
|
Axsome Therapeutics
AXSM
|
-8.03 | $ 162.28 | -0.98 % | $ 8.07 B | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | ||
|
Aytu BioScience
AYTU
|
-1.92 | $ 2.56 | -0.58 % | $ 16.1 M | ||
|
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B |